Oceanside, California
United States
43
2024-11-07
The entities that hold a legal rights for patent applications filed by inventor Veltmeyer James:
James Veltmeyer from Oceanside, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Aneurysm Treatment by Exosomes
#2 | 2024-09-19Generation and Utility of B Cell Subsets for Treatment of Chronic Obstructive Pulmonary Disease
#3 | 2024-08-15Enhancement of Anti-Angiogenic Cancer Immunotherapy by Abortogenic Agents
#4 | 2024-07-18PREDICTION OF STEM CELL THERAPY RESPONSIVENESS BY QUANTIFICATION OF PRE-EXISTING B REGULATORY CELLS
#5 | 2024-07-11MESENCHYMAL STEM CELL THERAPY OF EPILEPSY AND SEIZURE DISORDERS
#6 | 2024-07-04ENHANCED EFFICACY OF TOLEROGENIC VACCINATION
#7 | 2024-05-16TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MYELOID DERIVED SUPPRESSOR CELLS
#8 | 2024-04-25MESENCHYMAL STEM CELL THERAPY OF EPILEPSY AND SEIZURE DISORDERS
#9 | 2024-03-21TREATMENT OF BIPOLAR DISORDER USING MESENCHYMAL STEM CELLS AND MODIFICATION OF MESENCHYMAL STEM CELLS
#10 | 2024-03-14TREATMENT OF COPD BY STIMULATION OF STEM CELL MOBILIZATION
#11 | 2024-03-07GENE SILENCING THERAPY OF ACUTE RESPIRATORY DISORDER
#12 | 2024-02-15TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY MESENCHYMAL STEM CELL APOPTOTIC BODIES AND COMPOSITIONS THEREOF
#13 | 2024-02-01GENE MODIFIED IPSC DERIVED CELLULAR COMPOSITIONS FOR REGENERATION AND IMMUNE MODULATION
#14 | 2023-11-16INHIBITION AND REVERSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ENDOTHELIAL CELL REGENERATION
#15 | 2023-06-22INDUCTION OF CONCURRENT PULMONARY IMMUNE MODULATION AND REGENERATION BY PROTEIN MEDIATED CONJUGATION OF IMMUNE REGULATORY CELLS WITH ENDOGENOUS PROGENITOR CELLS
#16 | 2023-04-06REDUCTION OF NEUTROPHIL EXTRACELLULAR TRAP FORMATION BY MESENCHYMAL STEM CELLS AND THEIR EXOSOMES
#17 | 2023-03-23Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cells
#18 | 2023-03-16IVERMECTIN COMPOSITIONS FOR TREATMENT OF COVID-19
#19 | 2023-02-23UMBILICAL CORD MESENCHYMAL STEM CELLS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG DEGENERATION
#20 | 2023-02-23ENHANCEMENT OF UMBILICAL CORD MESENCHYMAL STEM CELL THERAPEUTIC ACTIVITY BY STIMULATORS OF T REGULATORY CELLS AND/OR CELLS EXPRESSING CD73
#21 | 2023-02-16INDUCTION OF NEUROGENESIS USING UMBILICAL CORD DERIVED MESENCHYMAL STEM CELLS AND DERIVATIVES THEREOF
#22 | 2023-01-12TREATMENT OF PARKINSON'S DISEASE BY IMMUNE MODULATION AND REGENERATIVE MEANS
#23 | 2022-12-22COMPOSITIONS CAPABLE OF STIMULATING IMMUNITY TOWARDS TUMOR BLOOD VESSELS
#24 | 2022-12-15TREATMENT OF COVID-19 LUNG INJURY USING UMBILICAL CORD PLASMA BASED COMPOSITIONS
#25 | 2022-11-24LITHIUM AS A MONOTHERAPY AND/OR STEM CELL ADJUVANT THERAPY FOR PULMONARY FIBROSIS
#26 | 2022-11-24IMMUNOTHERAPIES FOR TARGETING OF TUMOR VASCULATURE
#27 | 2022-10-13Amelioration and Treatment of Opioid Addiction
#28 | 2022-09-29CHIMERIC CELLS COMPRISING DENDRITIC CELLS AND ENDOTHELIAL CELLS RESEMBLING TUMOR ENDOTHELIUM
#29 | 2022-09-22PLURIPOTENT STEM CELL DERIVED DENDRITIC CELLS AND ENGINEERED DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY
#30 | 2022-09-08THERAPEUTIC MONOCYTES FOR PREVENTION OF SUICIDAL IDEATION
#31 | 2022-08-25EX VIVO GENERATION OF IMMUNOCYTES RECOGNIZING BROTHER OF THE REGULATOR OF IMPRINTED SITES (BORIS) EXPRESSING CANCER STEM CELLS
#32 | 2022-08-11STIMULATION OF NATURAL KILL CELL MEMORY BY ADMINISTRATION OF DENDRITIC CELLS
#33 | 2022-07-28STIMULATION OF DENDRITIC CELL ACTIVITY BY HOMOTAURINE AND ANALOGUES THEREOF
#34 | 2022-06-23IMMUNOTHERAPY FOR OPIOID ADDICTION
#35 | 2022-06-09TREATMENT OF MAJOR DEPRESSIVE DISORDER AND SUICIDAL IDEATIONS THROUGH STIMULATION OF HIPPOCAMPAL NEUROGENESIS UTILIZING PLANT-BASED APPROACHES
#36 | 2022-05-12Prevention of Pathological Coagulation in COVID-19 and other Inflammatory Conditions
#37 | 2022-03-31AUGMENTATION OF NATURAL KILLER CELL ACTIVITY AND INDUCTION OF CYTOTOXIC IMMUNITY USING LEUKOCYTE LYSATE ACTIVATED ALLOGENEIC DENDRITIC CELLS: STEMVACS
#38 | 2022-02-10Prevention of neuroinflammation associated memory loss using nutraceutical compositions
#39 | 2022-02-03Neuroprotection and neuroregeneration by pterostilbene and compositions thereof
#40 | 2022-01-27ADDITIVE AND/OR SYNERGISTIC COMBINATIONS OF METFORMIN WITH NUTRACEUTICALS FOR THE PREVENTION, INHIBITION AND TREATMENT OF SARS-COV-2 AND ASSOCIATED COVID-19
#41 | 2022-01-25Nutraceuticals for suppressing indolamine 2,3 deoxygenase
#42 | 2021-12-23Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
#43 | 2021-12-16Nutraceuticals for Reducing Myeloid Suppressor Cells
5267727 ⎘